Switzerland· 45342001
Tracrium 10mg/ml, Injektions-/Infusionslösung
A atracurium product, registered in Switzerland by Aspen Pharma Schweiz GmbH and dispensed under Swissmedic category B. The same ATC class is registered in 13 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Atracurium is registered in 13 of 19 countries.
Countries holding a registration under ATC M03AC04 (atracurium), each read from that country’s own register.
- This record: Switzerland
- 8 of them publish a price we can compare per daily dose
Atracurium · ATC M03AC04
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
- Manufacturer
- Aspen Pharma Schweiz GmbH
- Country
- Switzerland (CH)
- ATC code
- M03AC04
- ATC class
- Atracurium
- Defined daily dose
- 38.5 mg, P
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
60 interactions on record for atracurium.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Atracurium · interactions on record
60 records
- 12 severe
- 44 moderate
- 4 minor
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- ParomomycinA07AA06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under M03AC04
Atracurium, as other registers publish it.
- IrelandAtracurium 10 mg/ml solution for injection/infusionHikma Farmacêutica (Portugal) S.A.
- FinlandAtracurium AbbottAbbott Scandinavia AB
- FinlandAtracurium AlpharmaAlpharma A/S
- IrelandAtracurium besilate 10 mg/ml solution for injection/infusionAS Kalceks
- United KingdomAtracurium besilate 10mg/5ml solution for injection vialsSpecial Order
- United KingdomAtracurium besilate 250mg/25ml solution for injection ampoulesActavis UK Ltd
- United KingdomAtracurium besilate 250mg/25ml solution for injection ampoulesA A H Pharmaceuticals Ltd
- United KingdomAtracurium besilate 250mg/25ml solution for injection vialsPfizer Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e27b8e7d-967b-49a2-8762-c50cd42b9437 GET /v1/drugs/e27b8e7d-967b-49a2-8762-c50cd42b9437?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about atracurium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.